Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Nitrile compound >  enbucrilate

enbucrilate

Basic information Safety Supplier Related

enbucrilate Basic information

Product Name:
enbucrilate
Synonyms:
  • BUTYLCYANOACRYLATE
  • 2-cyano-2-propenoic acid butyl ester
  • 2-Propenoic acid, 2-cyano-, butyl ester
  • 2-propenoic,2-cyano-,butyl ester
  • enbucrilate
  • n-Butyl 2-Cyanoacrylate
  • NBCA n-butyl cyanoacrylate tissue adhesive
  • Enbucrilate 98%min
CAS:
6606-65-1
MF:
C8H11NO2
MW:
153.18
EINECS:
229-552-2
Product Categories:
  • acrylate
Mol File:
6606-65-1.mol
More
Less

enbucrilate Chemical Properties

Boiling point:
bp1.8 68°
Density 
d20 0.989
vapor pressure 
1.3hPa at 20℃
refractive index 
n20D 1.4424; nD25 1.4410
Flash point:
closed cup: >176°F (>80°C)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
solubility 
Chloroform (Sparingly), Ethyl Acetate (Slightly)
form 
Oil
color 
Colourless
InChI
InChI=1S/C8H11NO2/c1-3-4-5-11-8(10)7(2)6-9/h2-5H2,1H3
InChIKey
JJJFUHOGVZWXNQ-UHFFFAOYSA-N
SMILES
C(OCCCC)(=O)C(C#N)=C
LogP
1.29 at 25℃ and pH7
Surface tension
34.28mN/m at 1g/L and 20℃
EPA Substance Registry System
Butyl 2-cyanoacrylate (6606-65-1)
More
Less

enbucrilate Usage And Synthesis

Uses

Enbucrilate is bacteriostatic and its use is usually painless. It is used as an adhesive for lacerations of the skin, and in the treatment of bleeding from vascular structures.

Definition

ChEBI: Enbucrilate is a nitrile and an alpha,beta-unsaturated monocarboxylic acid.

Clinical Use

Enbucrilate injection of esophageal varices was first reported by Gotlib and Zimmermann in 1984 and has since been used in the acute treatment of bleeding esophageal varices in a few series, including randomized trials against band ligation for acute bleeding and for eradication of high-risk varices. Enbucrilate is often combined with lipiodol (lipid-soluble ethiodized oil) for injection of bleeding gastrointestinal ulcers; the advantage of this combination is slower polymerization of enbucrilate, with more accurate administration of the glue, but a potential disadvantage is a higher frequency of embolism, several cases of which have been reported. Overall, control of bleeding by using enbucrilate was found to be similar to band ligation, but rebleeding rates were higher. In addition, glue injection was found to be associated with sinus and fistula formation, in one case resulting in catastrophic bleeding. The higher complication rate may be explained by an increased risk of extravascular injection and attendant histotoxic reactions owing to the smaller lumen diameter.

enbucrilate Preparation Products And Raw materials

Raw materials

enbucrilateSupplier

Zhengzhou Alpha Chemical Co. LTD Gold
Tel
0371-0371-53732842 13383863444
Email
3002612166@qq.com
Suzhou Haiben Pharmaceutical Co., Ltd Gold
Tel
18012778619
Email
93743011@qq.com
Jiangsu yize medical technology co. LTD Gold
Tel
18962082606
Email
3394205705@qq.com
Cato Research Chemicals Inc. Gold
Tel
020-81960175-877 18933936954
Email
tianwen.zhan@cato-chem.com
Shanghai Harmony Bio-Pharmaceutical Technology Co., Ltd. Gold
Tel
021-18019086215 18019086215
Email
ljf_navigator@163.com